Clinical Overview of Progressive Fibrotic Interstitial Lung Disease

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease

Interstitial lung diseases (ILD) on the whole have variable prognoses, but there are those which manifest with fibrosis and are characterized by disease progression. Chief among these is idiopathic pulmonary fibrosis, but other ILDs, including autoimmune ILD and chronic hypersensitivity pneumonitis,...

Full description

Bibliographic Details
Main Author:	Amy Hajari Case
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Medicine
Subjects:	pulmonary fibrosis interstitial lung disease (ILD) connective tissue disease-associated ILD hypersensitivity pneumonitis (HP) antifibrotic
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.858339/full

Similar Items

What is new in the treatment of interstitial lung diseases
by: Vasilina Sotiropoulou, et al.
Published: (2023-06-01)

Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response
by: Willis S. Bowman, et al.
Published: (2021-05-01)

Editorial: Interstitial Lung Disease Around the World
by: Marlies Wijsenbeek, et al.
Published: (2022-03-01)

Lessons from the interstitial lung disease-India registry: A proposed practical scheme of classification of diffuse parenchymal lung diseases in the Indian subcontinent
by: Parthasarathi Bhattacharyya
Published: (2018-01-01)

Cystic lung lesion following transbronchial lung cryobiopsy: Case report and systematic review
by: Srikant Kashinath Malegaonkar, et al.
Published: (2023-01-01)

Bridges of Pulmonology 2023 proceedings: Highlights in the field of interstitial lung diseases
by: Vasilina Sotiropoulou, et al.
Published: (2024-03-01)

Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience
by: Maria Boutel, et al.
Published: (2023-03-01)

A Rare Pediatric Case of Severe Bird Fancier’s Lung Presented with Viral Pneumonitis-Like Picture
by: Basel Habra, et al.
Published: (2018-11-01)

Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
by: Lutz B. Jehn, et al.
Published: (2023-02-01)

Smoking Related Interstitial Lung Disease - High Resolution Computed Tomography (HRCT) findings in 40 smokers
by: Youssriah Yahia Sabri, et al.
Published: (2014-06-01)

Diagnosing interstitial lung disease by multidisciplinary discussion: A review
by: Laura M. Glenn, et al.
Published: (2022-09-01)

Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases
by: Minna Mononen, et al.
Published: (2022-08-01)

Idiopathic and immune‐related pulmonary fibrosis: diagnostic and therapeutic challenges
by: Andrew McLean‐Tooke, et al.
Published: (2019-01-01)

Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases
by: Matthias Griese
Published: (2022-03-01)

Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria
by: Francesco Bozzao, et al.
Published: (2023-04-01)

The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study
by: MB Johansen, et al.
Published: (2023-01-01)

Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases
by: Stefan Cristian Stanel, et al.
Published: (2023-02-01)

Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study
by: Kyung-In Joung, et al.
Published: (2023-03-01)

Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
by: Marco Sebastiani, et al.
Published: (2023-11-01)

Expert Opinion Guidance on the Detection of Early Connective Tissue Diseases in Interstitial Lung Disease
by: Namas R, et al.
Published: (2023-05-01)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
by: Julien Guiot, et al.
Published: (2022-04-01)

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial
by: Matthias Griese, et al.
Published: (2020-04-01)

Clinical and Functional Characteristics of Interstitial Lung Disease in Algeria: A Single-Center Prospective Study
by: Abdelbassat Ketfi, et al.
Published: (2023-12-01)

Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease
by: Katie Uhl, et al.
Published: (2023-10-01)

Childhood interstitial lung disease: When to suspect and what to do
by: Grazia Fenu, et al.
Published: (2024-06-01)

Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay
by: Jun-Jun Yeh, et al.
Published: (2022-05-01)

The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
by: Gaetano Rea, et al.
Published: (2024-01-01)

Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease
by: Di Sun, et al.
Published: (2022-01-01)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
by: Elisabetta Zanatta, et al.
Published: (2023-05-01)

Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease
by: Janet Johnston, et al.
Published: (2023-09-01)

Risk factors for progression of pulmonary fibrosis: a single-centered, retrospective study
by: Jia-Jia Fan, et al.
Published: (2024-02-01)

Progressive fibrotic interstitial lung disease
by: Carlos A C Pereira, et al.
Published: (2023-08-01)

A Cross-Sectional Survey of Pulmonologists Working at Non-ILD Centers in the United States
by: Biehl R, et al.
Published: (2023-07-01)

Editorial: Fibrotic Lung Disease—“Lumping” the Progressive Phenotype
by: Tejaswini Kulkarni, et al.
Published: (2022-05-01)

Correlation of high resolution CT patterns with pulmonary function tests in patients with interstitial lung diseases
by: Khaled Hussein, et al.
Published: (2016-07-01)

Predictors of Progression and Mortality in Patients with Chronic Hypersensitivity Pneumonitis: Retrospective Analysis of Registry of Fibrosing Interstitial Lung Diseases
by: Natalia V. Trushenko, et al.
Published: (2023-02-01)

Post-COVID lung fibrosis: The tsunami that will follow the earthquake
by: Zarir F Udwadia, et al.
Published: (2021-01-01)

Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg)
by: Ekaterina Krauss, et al.
Published: (2020-08-01)

Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases
by: Yunxin Lai, et al.
Published: (2021-11-01)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
by: Carla R. Copeland, et al.
Published: (2021-10-01)